Holen Sie sich die Stockscreener-App
19.98
5.80%
1.095
Handel nachbörslich:
20.18
0.195
+0.98%
Schlusskurs vom Vortag:
$18.89
Offen:
$19.05
24-Stunden-Volumen:
361.22K
Relative Volume:
0.72
Marktkapitalisierung:
$980.65M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-85.21M
KGV:
-10.57
EPS:
-1.89
Netto-Cashflow:
$-68.53M
1W Leistung:
+6.08%
1M Leistung:
-10.98%
6M Leistung:
-7.05%
1J Leistung:
-7.13%
1-Tages-Spanne:
$18.13
$20.11
1-Wochen-Bereich:
$17.43
$20.11
52-Wochen-Spanne:
$13.30
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
Firmenname
Enliven Therapeutics Inc
Sektor
Branche
Telefon
720-647-8519
Adresse
6200 LOOKOUT ROAD, BOULDER
Vergleichen Sie ELVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
19.98 | 1.11B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | Goldman | Buy |
| 2024-12-13 | Eingeleitet | BTIG Research | Buy |
| 2024-09-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-09 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Enliven Therapeutics Inc Aktie (ELVN) Neueste Nachrichten
Enliven Posts Loss Beat and Cash Surge - The Motley Fool
Enliven Posts Loss Beat and Cash Surge - Nasdaq
Enliven Therapeutics, Inc Q2 Loss Climbs - Nasdaq
Enliven Therapeutics: A High-Conviction Biotech Play in Precision Oncology - AInvest
Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update - PR Newswire
Published on: 2025-08-13 08:33:59 - Newser
What MACD signals say about Enliven Therapeutics Inc.M&A Rumor & Low Volatility Stock Suggestions - Newser
Is Enliven Therapeutics Inc. stock bottoming outJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
Will Enliven Therapeutics Inc. stock split in the near futureTrading Watchlist with Real Time Filters - Newser
Unlocking Value Post-Lock-Up: Analyzing Enliven Therapeutics' Recent Equity Raise and Implications for Investor Strategy - AInvest
The Strategic Timing of Enliven Therapeutics' $230M Raise and Lock-Up Expiration: A Playbook for Warrant Holders and Institutional Investors - AInvest
Real time social sentiment graph for Enliven Therapeutics Inc.Forecasting Stock Moves with AI Insights - Newser
What makes Enliven Therapeutics Inc. stock price move sharplyFree Breakout Confirmation With Entry Tracker - Newser
Can volume confirm reversal in Enliven Therapeutics Inc.Free Fast Return Equity Trade Forecast - Newser
Using AI based signals to follow Enliven Therapeutics Inc.Equity Forecast with Predictive AI Screener - Newser
Enliven Therapeutics' COO Patel Anish sells shares on August 7 at $18.2 and $18.93. - AInvest
How Enliven Therapeutics Inc. stock performs during market volatilityFree Reliable Alerts for Daily Stock Movers - Newser
Why Enliven Therapeutics Inc. stock attracts strong analyst attention3-Day Market Movement Forecast Analysis - Newser
Institutional scanner results for Enliven Therapeutics Inc.Asset Growth Pattern and Return Summary - Newser
RSI Suggests Rebound May Be Near in Enliven Therapeutics Inc.Growth Based Investment Plan Guidance Highlighted - metal.it
Enliven Therapeutics (ELVN) Projected to Post Earnings on Tuesday - Defense World
Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) PT at $41.20 - Defense World
Federated Hermes Inc. Has $1.36 Million Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Chartists Watching For Breakout in Enliven Therapeutics Inc.Stable Entry High Return Opportunities in Focus - metal.it
Sectors Driving Future Growth for Enliven Therapeutics Inc. StockFree Smart Trade Plans With Risk Protection - Newser
Enliven Therapeutics Inc. Inches Above Key Support — Safe to HoldReliable Investment Entry Signals Confirmed by Charts - metal.it
Why is Enliven Therapeutics Inc. stock attracting strong analyst attentionBuild a portfolio that outperforms the market - Jammu Links News
What are the latest earnings results for Enliven Therapeutics Inc.Track emerging stocks with high growth potential - Jammu Links News
Should I hold or sell Enliven Therapeutics Inc. stock in 2025Achieve rapid returns with smart investment plans - Jammu Links News
What analysts say about Enliven Therapeutics Inc. stockAchieve breakthrough financial results - Jammu Links News
Is it the right time to buy Enliven Therapeutics Inc. stockDiscover high-impact investment opportunities - Jammu Links News
Is Enliven Therapeutics Inc. a good long term investmentAchieve consistent profits with proven methods - Jammu Links News
How does Enliven Therapeutics Inc. generate profit in a changing economyDynamic profit opportunities - Jammu Links News
Is Enliven Therapeutics Inc. a growth stock or a value stockGet alerts on high-potential market moves - Jammu Links News
How does Enliven Therapeutics Inc. compare to its industry peersDiscover breakthrough stocks with expert help - Jammu Links News
Does Enliven Therapeutics Inc. stock perform well during market downturnsFree AI-Backed Trading Signals - Jammu Links News
Is Enliven Therapeutics Inc. stock overvalued or undervaluedBreakout Stocks Tracker For Consistent Profits - jammulinksnews.com
How strong is Enliven Therapeutics Inc. company’s balance sheetFree Stock Recommendation With Proven Results - jammulinksnews.com
Using economic indicators to assess Enliven Therapeutics Inc. potentialValue Holding Return Summary With Outlook - Newser
What MACD and RSI say about Enliven Therapeutics Inc.Free Quick Gain Stock Watch With Indicators - Newser
Forecasting Enliven Therapeutics Inc. price range with options dataGrowth Based Investment Plan Guidance Highlighted - metal.it
Pattern recognition hints at Enliven Therapeutics Inc. upsideOptimized Watchlist With Daily Adjustments Launched - metal.it
Published on: 2025-07-30 13:46:37 - beatles.ru
Short Term Trend Reversal in Enliven Therapeutics Inc. PossibleTop Performing Stock Insights Released Daily - beatles.ru
Finanzdaten der Enliven Therapeutics Inc-Aktie (ELVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):